Insider Transactions in Q2 2022 at Castle Biosciences Inc (CSTL)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 10
2022
|
Mara G. Aspinall Director |
BUY
Exercise of conversion of derivative security
|
Direct |
830
+2.55%
|
-
|
|
Jun 10
2022
|
Daniel Bradbury Director |
BUY
Exercise of conversion of derivative security
|
Direct |
830
+50.0%
|
-
|
|
Jun 10
2022
|
G Bradley Cole Director |
BUY
Exercise of conversion of derivative security
|
Direct |
830
+50.0%
|
-
|
|
Jun 10
2022
|
Miles Harrison Director |
BUY
Exercise of conversion of derivative security
|
Direct |
830
+50.0%
|
-
|
|
May 12
2022
|
Tiffany Olson Director |
BUY
Open market or private purchase
|
Direct |
1,320
+25.91%
|
$23,760
$18.77 P/Share
|
|
May 12
2022
|
Frank Stokes Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+23.85%
|
$12,000
$3.38 P/Share
|
|
May 10
2022
|
Tiffany Olson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
486
+50.0%
|
-
|
|
Apr 26
2022
|
Daniel Bradbury Director |
BUY
Grant, award, or other acquisition
|
Indirect |
60,997
+19.85%
|
-
|
|
Apr 26
2022
|
Tobin W Juvenal Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
2,230
+50.0%
|
-
|
|
Apr 26
2022
|
Derek J Maetzold Pres. & Chief Exec. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,311
+9.95%
|
-
|
|
Apr 26
2022
|
Kristen M Oelschlager Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,692
+5.95%
|
-
|
|
Apr 26
2022
|
Frank Stokes Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,114
+11.27%
|
-
|